EcoDrugPlus

Presenilin 1

Ensembl ID : ENSCHAG00000018476
Gene Symbol: PSEN1
3 Cross references
202 Possible Orthologues:

Presenilin 2

Ensembl ID : ENSCHAG00000014780
Gene Symbol: PSEN2
3 Cross references
206 Possible Orthologues:

Probable Histone Deacetylase 1-B

Ensembl ID : ENSCHAG00000021775
Gene Symbol: LOC105892066
3 Cross references
307 Possible Orthologues:

Progesterone Receptor

Ensembl ID : ENSCHAG00000016525
Gene Symbol: PGR
1 Cross references
193 Possible Orthologues:

Prostaglandin D2 Receptor 2

Ensembl ID : ENSCHAG00000026193
Gene Symbol: PTGDR2
1 Cross references
145 Possible Orthologues:

Prostaglandin E Receptor 1a (Subtype Ep1)

Ensembl ID : ENSCHAG00000025700
Gene Symbol: PTGER1A
1 Cross references
171 Possible Orthologues:

Prostaglandin E Receptor 2a (Subtype Ep2)

Ensembl ID : ENSCHAG00000024271
Gene Symbol: PTGER2A
1 Cross references
203 Possible Orthologues:

Prostaglandin E Receptor 2b (Subtype Ep2)

Ensembl ID : ENSCHAG00000012783
Gene Symbol: PTGER2B
1 Cross references
172 Possible Orthologues:

Prostaglandin E Receptor 3

Ensembl ID : ENSCHAG00000012359
Gene Symbol: PTGER3
1 Cross references
197 Possible Orthologues:

Prostaglandin E Receptor 4

Ensembl ID : ENSCHAG00000010791
Gene Symbol: PTGER4
3 Cross references
202 Possible Orthologues:

Prostaglandin E2 Receptor Ep1 Subtype-Like

Ensembl ID : ENSCHAG00000015479
Gene Symbol: LOC105898754
3 Cross references
163 Possible Orthologues:

Prostaglandin E2 Receptor Ep4 Subtype-Like

Ensembl ID : ENSCHAG00000018473
Gene Symbol: LOC105889279
3 Cross references
202 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).